Herman Wong Selected Research

OGT 719

1/2004

A phase I safety and pharmacokinetic study of OGT 719 in patients with liver cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Herman Wong Research Topics

Disease

3	Hepatocellular Carcinoma (Hepatoma) 01/2008 - 01/2004
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 09/2007 - 01/2005
1	Disease Progression 09/2007
1	Neutropenia 09/2007
1	Neoplasms (Cancer) 11/2005
1	Liver Neoplasms (Liver Cancer) 01/2004
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 10/2002

Drug/Important Bio-Agent (IBA)

2	Cisplatin (Platino)FDA LinkGeneric 09/2007 - 01/2005
2	Etoposide (VP 16)FDA LinkGeneric 01/2005 - 10/2002
1	TeaIBA 01/2008
1	Ethiodized Oil (Ethiodol)FDA Link 01/2008
1	Ethanol (Ethyl Alcohol)IBA 01/2008
1	Irinotecan (Camptosar)FDA LinkGeneric 09/2007
1	Docetaxel (Taxotere)FDA Link 09/2007
1	alpha-Fetoproteins (alpha-Fetoprotein)IBA 11/2005
1	PlatinumIBA 01/2005
1	Gemcitabine FDA Link 01/2005
1	OGT 719IBA 01/2004
1	Asialoglycoprotein ReceptorIBA 01/2004
1	Topoisomerase I InhibitorsIBA 10/2002
1	Topotecan (Hycamtin)FDA LinkGeneric 10/2002

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 09/2007
1	Therapeutics 11/2005